Author

Simon Garinet

Dana-Farber Cancer InstituteORCID 0000-0002-2182-8793Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:DNA methylation· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

Brad J. FortunatoiD· 2 shared Dory A. FreemaniD· 2 shared Hunter SavignanoiD· 2 shared Jacob E. BerchuckiD· 2 shared Ji-Heui SeoiD· 2 shared Jillian O’Toole· 2 shared John CanniffiD· 2 shared Karl SemaaniD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Brad J. FortunatoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsJournal of Clinical InvestigationPeer-reviewedFeb 1, 2026

Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profiling

Simon Garinet, Karl Semaan, Jiao Li…·Srinivas Raghavan Viswanathan

This paper detects and monitors translocation renal cell carcinoma (tRCC) using plasma cell-free epigenomic profiling, achieving high accuracy in distinguishing tRCC from other cancers and healthy controls.

7 citationstop 1%

humanDNA methylation

GenomicsCell ReportsPeer-reviewedJun 1, 2024

Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma

Talal El Zarif, Karl Semaan, Marc Eid…·Sylvan C. Baca

The paper identifies epigenomic signatures in sarcomatoid renal cell carcinoma (sRCC) that predict response to immune checkpoint inhibitors and are detectable in plasma, enabling non-invasive diagnosis.

30 citationstop 2%

humanDNA methylation